Opinion

Video

Overview of Intrarenal Pressure (IRP)

Author(s):

Michelle Semins, MD,Seth Bechis, MD

Michelle Semins, MD, details the variability in intrarenal pressures, explaining that while a clear safe threshold is unknown, pressures over 30-40 might be dangerous; she lists factors influencing these pressures, like inflow/outflow and scope size, and mentions potential complications from prolonged high pressures, such as urosepsis.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      Christina Ching, MD, on study of follow-up after pediatric stone surgery
      Christina Ching, MD, on study of follow-up after pediatric stone surgery
      Marcelino Rivera, MD, on potential future advancements in stone disease, BPH
      Marcelino Rivera, MD, on potential future advancements in stone disease, BPH
      Human kidney stones | Image Credit: © freshidea - stock.adobe.com
      Future directions and research on the CVAC System for kidney stones
      Thomas Chi, MD, MBA, answers a question during a Zoom video interview
      Dr. Thomas Chi on the economics of the CVAC system for kidney stones
      Human kidney stones | Image Credit: © freshidea - stock.adobe.com
      How the CVAC System compares with URS for treating kidney stones
      Thomas Chi, MD, MBA, answers a question during a Zoom video interview
      Dr. Thomas Chi on the CVAC System for treating kidney stones
      Victoria S. Edmonds, MD, answers a question during a Zoom video interview
      Victoria S. Edmonds, MD, on reimbursement disparities for urolithiasis treatments
      Human kidney stones | Image Credit: © freshidea - stock.adobe.com
      Higher patient complexity associated with lower reimbursement for ureteroscopy
      Kari Tikkinen, MD, provides an update on the APPEAL trial
      Kari Tikkinen, MD, provides an update on the APPEAL trial
      DNA strand illustration | Image Credit: © Radomir Jovanovic - stock.adobe.com
      What criteria should be used when considering genetic testing in patients with stones?
      Related Content
      FDA updates in urology: February 2025
      March 3rd 2025

      FDA updates in urology: February 2025

      Hannah Clarke
      A recap of the FDA submissions and regulatory decisions in urology from February 2025.
      Why kidney stones will become more prevalent over time
      February 17th 2022

      Why kidney stones will become more prevalent over time

      Urology Times staff
      “The prevalence of kidney stones has increased over 80% over the last 30 years, and the epidemiology has changed such that it's beginning at a younger age now,” says Gregory Tasian, MD, MSc, MSCE.
      FDA awards orphan drug, rare pediatric disease designations to ABO-101 for PH1
      February 5th 2025

      FDA awards orphan drug, rare pediatric disease designations to ABO-101 for PH1

      Hannah Clarke
      A phase 1/2 trial of ABO-101 is expected to launch in the first half of 2025.
      Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters
      September 9th 2021

      Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

      Urology Times staff
      “You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.
      Published ASPIRE data show noninferior stone-free rate with SURE vs URS
      December 23rd 2024

      Published ASPIRE data show noninferior stone-free rate with SURE vs URS

      Hannah Clarke
      The SURE procedure also demonstrated significantly better outcomes on the study’s secondary end points of stone clearance and residual stone volume.
      FDA greenlights phase 1/2 trial of gene editing therapy for primary hyperoxaluria 1
      December 19th 2024

      FDA greenlights phase 1/2 trial of gene editing therapy for primary hyperoxaluria 1

      Hannah Clarke
      The redePHine trial is expected to launch in the first half of 2025.
      © 2025 MJH Life Sciences

      All rights reserved.